Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Longitudinal Assessment of Disease Severity in Subjects With Dystrophic Epidermolysis Bullosa (DEB)

NCT01768026 is registered in ClinicalTrials.gov with Lotus Tissue Repair, Inc. as lead sponsor.

NCT NCT01768026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01768026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Longitudinal Assessment of Disease Severity in Subjects With Dystrophic Epidermolysis Bullosa (DEB)
Lead sponsor
Lotus Tissue Repair, Inc.
Phase
Observational
Overall status
Withdrawn
Start date
February 28, 2013
Completion date
September 30, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dystrophic epidermolysis bullosa